From scarcity to solutions: Therapeutic strategies to restore adipose tissue functionality in rare disorders of lipodystrophy
Diabetic Medicine · 2023
DOI: 10.1111/dme.15214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetic Medicine, 2023. Verfasst von Mansi Tiwari und 1 weiteren Autor:innen. Beteiligte Einrichtung: The Rowett Institute, University of Aberdeen, Aberdeen, UK. Hauptthemen laut MEDLINE: Lipodystrophy, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Diabetes UK, University of Aberdeen.
Abstract (Originalsprache)
Aims
Lipodystrophy is a rare disorder characterised by abnormal or deficient adipose tissue formation and distribution. It poses significant challenges to affected individuals, including the development of severe metabolic complications like diabetes and fatty liver disease. These conditions are often chronic, debilitating and life‐threatening, with limited treatment options and a lack of specialised expertise. This review aims to raise awareness of lipodystrophy disorders and highlights therapeutic strategies to restore adipose tissue functionality.
Methods
Extensive research has been conducted, including both historical and recent advances. We have examined and summarised the literature to provide an overview of potential strategies to restore adipose tissue functionality and treat/reverse metabolic complications in lipodystrophy disorders.
Results
A wealth of basic and clinical research has investigated various therapeutic approaches for lipodystrophy. These include ground‐breaking methods such as adipose tissue transplantation, innovative leptin replacement therapy, targeted inhibition of lipolysis and cutting‐edge gene and cell therapies. Each approach shows great potential in addressing the complex challenges posed by lipodystrophy.
Conclusions
Lipodystrophy disorders require urgent attention and innovative treatments. Through rigorous basic and clinical research, several promising therapeutic strategies have emerged that could restore adipose tissue functionality and reverse the severe metabolic complications associated with this condition. However, further research and collaboration between academics, clinicians, patient advocacy groups and pharmaceutical companies will be crucial in transforming these scientific breakthroughs into effective and viable treatment options for individuals and families affected by lipodystrophy. Fostering such interdisciplinary partnerships could pave the way for a brighter future for those battling this debilitating disorder.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Rowett Institute, University of Aberdeen, Aberdeen, UK.
- Aberdeen Cardiovascular and Diabetes Centre, University of Aberdeen, Aberdeen, UK.
ORCID-Profile: Mansi Tiwari, George D Mcilroy
Förderung
- Diabetes UK
- University of Aberdeen
Zitieren
APA
Tiwari, M., & Mcilroy, G. D. (2023). From scarcity to solutions: Therapeutic strategies to restore adipose tissue functionality in rare disorders of lipodystrophy. Diabetic Medicine. https://doi.org/10.1111/dme.15214
Vancouver
Tiwari M, Mcilroy GD. From scarcity to solutions: Therapeutic strategies to restore adipose tissue functionality in rare disorders of lipodystrophy. Diabetic Medicine. 2023. doi:10.1111/dme.15214
BibTeX
@article{Tiwari2023,
author = {Tiwari, Mansi and Mcilroy, George D},
title = {From scarcity to solutions: Therapeutic strategies to restore adipose tissue functionality in rare disorders of lipodystrophy},
journal = {Diabetic Medicine},
year = {2023},
doi = {10.1111/dme.15214}
}
EUVIMED